EGFR inhibitors in the treatment of colorectal cancer
This ar cle discusses the use of EGFR inhibitors in the treatment of pa ents with colorectal cancer. The mechanisms of their ac on, specifi c manifesta ons of toxicity are considered. A review of current literature data on the use of both approved for clinical use (cetuximab, panitumumab) and an -EGF...
Saved in:
| Main Authors: | M. В. Zabelin, A. D. Kaprin, A. A. Kostin, E. V. Gameeva, S. E. Varlamova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2018-09-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/295 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MOLECULAR MARKERS OF SENSITIVITY AND RESISTANCE OF COLORECTAL CANCER TO ANTI-EGFR T
by: A. O. Ivantsov, et al.
Published: (2016-04-01) -
THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE
by: M. I. Sluzhev, et al.
Published: (2021-10-01) -
Exploring research frontiers and emerging trends of tyrosine kinase inhibitors in the treatment of colorectal cancer
by: Xiaosong Li, et al.
Published: (2025-07-01) -
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity
by: Jeremy D. Kratz, et al.
Published: (2025-04-01) -
Case Report: A case of interstitial pneumonia in a colorectal cancer patient with a history of lung cancer treated with cetuximab
by: Yang Yang, et al.
Published: (2025-07-01)